Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

SAGE Therapeutics Company Profile (NASDAQ:SAGE)

Consensus Ratings for SAGE Therapeutics (NASDAQ:SAGE) (?)
Ratings Breakdown: 1 Sell Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $58.07 (6.40% upside)

Analysts' Ratings History for SAGE Therapeutics (NASDAQ:SAGE)
Show:
DateFirmActionRatingPrice TargetDetailsShare
4/27/2015Vetr Inc.UpgradeStrong Sell -> Sell$56.50ViewTweet This Rating  Share This Rating on StockTwits
4/20/2015Vetr Inc.DowngradeSell -> Strong Sell$53.25ViewTweet This Rating  Share This Rating on StockTwits
4/6/2015JPMorgan Chase & Co.Boost Price TargetOverweight$51.00 -> $58.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2015Canaccord GenuitySet Price TargetBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2015JPMorgan Chase & Co.Reiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
3/23/2015Vetr Inc.UpgradeStrong Sell -> Sell$50.68ViewTweet This Rating  Share This Rating on StockTwits
3/20/2015William BlairInitiated CoverageOutperform$75.00ViewTweet This Rating  Share This Rating on StockTwits
3/19/2015Vetr Inc.DowngradeSell -> Strong Sell$46.62ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuitySet Price TargetBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2015Canaccord GenuityReiterated RatingBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
2/24/2015Vetr Inc.UpgradeSell -> Hold$46.12ViewTweet This Rating  Share This Rating on StockTwits
2/23/2015Vetr Inc.DowngradeHold -> Sell$46.00ViewTweet This Rating  Share This Rating on StockTwits
1/27/2015SunTrustInitiated CoverageBuy$67.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2015Canaccord GenuityReiterated RatingBuy$58.00ViewTweet This Rating  Share This Rating on StockTwits
1/9/2015JPMorgan Chase & Co.Reiterated RatingOverweight$51.00ViewTweet This Rating  Share This Rating on StockTwits
12/9/2014Leerink SwannBoost Price TargetOutperform$46.00 -> $54.00ViewTweet This Rating  Share This Rating on StockTwits
9/24/2014Goldman SachsUpgradeNeutral -> Buy$29.56 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Canaccord GenuityInitiated CoverageBuy$40.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014JPMorgan Chase & Co.Initiated CoverageOverweight$42.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Goldman SachsInitiated CoverageNeutral$38.00ViewTweet This Rating  Share This Rating on StockTwits
8/12/2014Leerink SwannInitiated CoverageOutperform$46.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 4/28/2013 forward)